Asia Pacific Pharmacovigilance and Drug Safety Software Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Software Type (Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, and Fully Integrated Software); Delivery Mode (On-premise, and Cloud-based); End User (Pharmaceutical and Biotech Companies, Contract Research Organizations (CROs), and Business Process Outsourcing (BPO) Firms)

Market Introduction

Pharmacovigilance (PV) plays an essential role in the healthcare system through assessment, monitoring, and finding of drug interactions and their effects in human. Pharmacovigilance helps companies to monitor any adverse drug reaction events during the trial phase and also during the post marketing period.

Thus, the globalization of pharmacovigilance are expected to create a significant demand for pharmacovigilance and drug safety software in the coming years, which is further anticipated to drive the pharmacovigilance and drug safety software market.

Countries in Asia-Pacific are expecting to witness huge challenge due to growing COVID-19. Considering the economic operations and geographic condition, the outbreak of disease has affected on medical tourism, manufacturer of medical equipment, laser systems, accessories and other problems posed by shortage of healthcare infrastructure in Asia-Pacific low-income countries. After the first case in December in Wuhan, China, the coronavirus has spread to at least 180 countries and regions. To prevent the spread of disease, restrictive measures have been taken in countries such as India, South Korea, Singapore, Malaysia, and by the Philippines. According to WHO, due to the rapidly changing risk of COVID-19 affected countries and constantly controlling outbreak trends, any additional health measures are likely to significantly interfere with international travel and trade. There is vast variation in the reporting standards across the Asia Pacific. While some countries have adopted electronic reporting, many organizations still use conventional methods of courier or hand delivery for paper reporting or electronic reporting via compact disc. Currently, electronic reporting and email submissions are compatible with COVID-19. However, all methods require efficient communication between pharmacovigilance teams, local legal representative, courier support and teams dispersed across various geographical locations, for example portal entry in the local language.

Get more information on this report :

Market Overview and Dynamics

The pharmacovigilance and drug safety software market in Asia Pacific is expected to grow from US$ 32.8 million in 2019 to US$ 62.7 million by 2027; it is estimated to grow at a CAGR of 8.2% from 2020 to 2027. Adverse drug reactions (ADRs) is an important public health problem, signifying a significant cause of illness and death. Because all drugs have the potential for adverse drug reactions, a risk-benefit analysis is necessary whenever a drug is prescribed. ADR reported by a patient or healthcare professional adds to safety monitoring and thus to the safe and effective use of medicines. The increasing amount of data generated through adverse drug reaction report need to be handled and stored carefully. All these data come in different forms, language, location, etc. To arrange these uniformly the automation systems/software are helpful. Thus, the rising incidences of adverse drug reactions (ADRs) are likely to drive the market’s growth.

Key Market Segments

In terms of software type, the adverse event reporting software segment accounted for the largest share of the Asia Pacific pharmacovigilance and drug safety software market in 2019. In terms of delivery mode, the on-premise segment held a larger market share of the pharmacovigilance and drug safety software market in 2019. In terms of end user, the contract research organizations segment held a larger market share of the pharmacovigilance and drug safety software market in 2019.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the Pharmacovigilance and drug safety software market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Veeva Systems, IQVIA Inc., AB Cube, ArisGlobal LLC, Sparta Systems, Oracle Corporation, Sarjen Systems Pvt. Ltd, EXTEDO, and Online Business Applications, Inc.

Reasons to buy report

To understand the Asia Pacific pharmacovigilance and drug safety software market landscape and identify market segments that are most likely to guarantee a strong return
Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia Pacific pharmacovigilance and drug safety software market
Efficiently plan M&A and partnership deals in Asia Pacific pharmacovigilance and drug safety software market by identifying market segments with the most promising probable sales
Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific pharmacovigilance and drug safety software market
Obtain market revenue forecast for market by various segments from 2021-2028 in Asia Pacific region.

ASIA PACIFIC PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SEGMENTATION

By Software Type

Fully Integrated Software
Adverse Event Reporting Software
Drug Safety Audits Software
Issue Tracking Software

By Delivery Mode

Cloud-based
On-premise

By End User

Contract Research Organizations
Pharmaceutical and Biotech Companies
Business Process Outsourcing

By Country

Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia Pacific

Companies Mentioned

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Pharmacovigilance and Drug Safety Software Market – By Software Type

1.3.2 Pharmacovigilance and Drug Safety Software Market – By Delivery Mode

1.3.3 Pharmacovigilance and Drug Safety Software Market – By End User

1.3.4 Asia Pacific Pharmacovigilance and Drug Safety Software Market – By Country

2. Asia Pacific Pharmacovigilance and Drug Safety Software Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Pharmacovigilance and Drug Safety Software Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Pharmacovigilance and Drug Safety Software Market- Asia Pacific PEST Analysis

4.3 Expert Opinion

5. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Incidences of Adverse Drug Reactions (ADRs)

5.1.2 Globalization of Pharmacovigilance

5.2 Market Restraints

5.2.1 Expensive Technology

5.3 Market Opportunities

5.3.1 Growth Opportunities in Developing Countries

5.4 Future Trends

5.4.1 Artificial Intelligence in Pharmacovigilance

5.5 Impact Analysis

6. Pharmacovigilance and Drug Safety Software Market – Asia Pacific Analysis

6.1 Asia Pacific Pharmacovigilance and Drug Safety Software Market Revenue Forecasts and Analysis

7. Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis and Forecasts To 2027 – By Software Type

7.1 Overview

7.2 Pharmacovigilance (PV) and Drug Safety Software Market, by Software Type, 2019 & 2027 (%)

7.3 Adverse Event Reporting Software Market

7.3.1 Overview

7.3.2 Adverse Event Reporting Software Market Revenue and Forecasts to 2027 (US$ Mn)

7.4 Drug Safety Audits Software

7.4.1 Overview

7.4.2 Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)

7.5 Issue Tracking Software

7.5.1 Overview

7.5.2 Issue Tracking Software Market Revenue and Forecasts to 2027 (US$ Mn)

7.6 Fully Integrated Software

7.6.1 Overview

7.6.2 Fully Integrated Software Market Revenue and Forecasts to 2027 (US$ Mn)

8. Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis and Forecasts To 2027 – By Delivery Mode

8.1 Overview

8.2 Pharmacovigilance (PV) and Drug Safety Software Market, By Delivery Mode 2019 & 2027 (%)

8.3 On-premise

8.3.1 Overview

8.3.2 On-premise Market Revenue and Forecasts to 2027 (US$ Mn)

8.4 Cloud- Based

8.4.1 Overview

8.4.2 Cloud Based Market Revenue and Forecasts to 2027 (US$ Mn)

9. Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis and Forecasts to 2027– By End User

9.1 Overview

9.2 Pharmacovigilance (PV) and Drug Safety Software Market, By End User, 2019 & 2027 (%)

9.3 Pharmaceutical and Biotech Companies Market

9.3.1 Overview

9.3.2 Pharmaceutical and Biotech Companies Market Revenue and Forecasts to 2027 (US$ Mn)

9.4 Contract Research Organizations (CROs) Market

9.4.1 Overview

9.4.2 Contract Research Organizations (CROs) Market Revenue and Forecasts to 2027 (US$ Mn)

9.5 Business Process Outsourcing (BPO) Firms Market

9.5.1 Overview

9.5.2 Business Process Outsourcing (BPO) Firms Market Revenue and Forecasts to 2027 (US$ Mn)

10. Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 – Geographical Analysis

10.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market

10.1.1 Overview

10.1.2 Asia Pacific Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)

10.1.3 Japan Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027(US$ Mn)

10.1.3.1 Japan Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.3.2 Japan Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)

10.1.3.3 Japan Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.3.4 Japan Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.1.4 China Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.4.1 China Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.4.2 China Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)

10.1.4.3 China Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.4.4 China Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.1.5 India Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.5.1 India Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.5.2 India Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)

10.1.5.3 India Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.5.4 India Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.1.6 South Korea Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.1 South Korea Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.2 South Korea Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)

10.1.6.3 South Korea Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.6.4 South Korea Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.1.7 Australia Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.1 Australia Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.2 Australia Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)

10.1.7.3 Australia Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.7.4 Australia Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.1.8 Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.1 Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.2 Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)

10.1.8.3 Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.8.4 Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on Asia Pacific Pharmacovigilance and Drug Safety Software Market

11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Pharmacovigilance and Drug Safety Software Market

12.3 Organic Developments

12.3.1 Overview

12.3.2 Organic Developments Done by Companies

12.4 Inorganic Developments

12.4.1 Overview

12.4.2 Inorganic Growth Strategies by Companies

13. COMPANY PROFILES

13.1 Veeva Systems

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 IQVIA Inc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 AB Cube

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 ArisGlobal LLC

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Sparta Systems

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Oracle Corporation

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Sarjen Systems Pvt. Ltd

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 EXTEDO

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Online Business Applications, Inc.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Japan Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 2. Japan Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 3. Japan Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 4. China Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 5. China Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 6. China Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 7. India Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 8. India Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 9. India Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 10. South Korea Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 11. South Korea Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 12. South Korea Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 13. Australia Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 14. Australia Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 15. Australia Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 16. Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 17. Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 18. Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 19. Organic Developments Done by Companies

Table 20. Recent Inorganic Growth Strategies by the Companies

Table 21. Glossary of Terms, Pharmacovigilance and Drug Safety Software Market

LIST OF FIGURES

Figure 1. Pharmacovigilance and Drug Safety Software Market Segmentation

Figure 2. Asia Pacific Pharmacovigilance and Drug Safety Software Market Overview

Figure 3. Adverse Event Reporting Software Segment Held Largest Share of Software Type in Pharmacovigilance and Drug Safety Software Market

Figure 4. Contract Research Organizations Segment Held Largest Share of End User in Pharmacovigilance and Drug Safety Software Market

Figure 5. China is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Pharmacovigilance and Drug Safety Software Market - Asia Pacific PEST Analysis

Figure 7. Pharmacovigilance and Drug Safety Software Market Impact Analysis of Driver and Restraints

Figure 8. Asia Pacific Pharmacovigilance and Drug Safety Software Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9. Pharmacovigilance (PV) and Drug Safety Software Market, by Software Type, 2019 & 2027 (%)

Figure 10. Adverse Event Reporting Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11. Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12. Issue Tracking Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13. Fully Integrated Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14. Pharmacovigilance (PV) and Drug Safety Software Market, by Delivery Mode 2019 & 2027 (%)

Figure 15. On-premise Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16. Cloud Based Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17. Pharmacovigilance (PV) and Drug Safety Software Market, by End User, 2019 & 2027 (%)

Figure 18. Pharmaceutical and Biotech Companies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19. Contract Research Organizations (CROs) Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20. Business Process Outsourcing (BPO) Firms Revenue and Forecasts to 2027 (US$ Mn)

Figure 21. Asia Pacific Pharmacovigilance and Drug Safety Software Market Revenue Overview, By Country, 2019 (US$ Mn)

Figure 22. Asia Pacific Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)

Figure 23. Japan Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24. China Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25. India Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26. South Korea Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27. Australia Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 28. Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 30. Growth Strategies in the Pharmacovigilance and Drug Safety Software Market

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific pharmacovigilance and drug safety software market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific pharmacovigilance and drug safety software market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the pharmacovigilance and drug safety software market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample